Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

The company suffered a huge share price blow as supply issues hit sales growth
Thursday 26 Oct 2017 Author: Lisa-Marie Janes

Shares in FTSE 100 woundcare specialist ConvaTec (CTEC) have fallen below the price at which it joined the stock market exactly a year ago. At 214.4p, they now trade 4.7% below the 225p IPO (initial public offering) price.

Supply issues have ‘severely impacted’ ConvaTec’s advanced wound and ostomy care division resulting in the company cutting its full year sales growth guidance.

Full year sales growth was cut from 4% to a range of 1% to 2%, causing the shares to drop more than 20% in value on 16 October.

‹ Previous2017-10-26Next ›